2,200 Remdesivir vials stocked by exporters seized in Mumbai

The FDA took the vials into its possession and would make them available to hospitals, an official said.

April 20, 2021 12:27 pm | Updated 12:28 pm IST - Mumbai

For representational purpose only.

For representational purpose only.

Police and FDA officials have raided two locations in Mumbai and seized 2,200 vials of Remdesivir stocked by exporters, an official said on Tuesday.

Remdesivir is listed for use in serious COVID-19 patients. In view of a sudden spike in demand of the drug due to the surge in COVID-19 cases , the Centre last week banned its export till the situation improves.

Acting on an information, the police and the Food and Drug Administration (FDA) officials conducted raids on Monday at two locations in suburban Andheri and New Marine Lines in south Mumbai, he said.

Also read: Coronavirus | Government asks drug makers to ramp up remdesivir production to full capacity

A total of 2,000 vials of Remdesivir belonging to a pharmaceutical company were recovered from an exporter's location in Marol area of Andheri (East), Mumbai police spokesperson S Chaitanya said in a statement.

Besides, 200 vials of the key anti-viral drug were recovered from another premises of an exporter in the New Marine Lines area, he said.

These vials were produced for overseas markets, but were stocked after the government imposed a ban on the export of the drug, he said.

The FDA took the 2,200 vials into its possession and would make them available to hospitals, the official said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.